For verified healthcare professionals
Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.
Pancreatic cancer: overcoming chemotherapy resistance using synthetic anti-miRs
Pancreatic cancer has a 5-year survival rate for patients diagnosed with this cancer is only 12%, the lowest among all solid malignancies.
